688 results on '"El-Chami, Mikhael F."'
Search Results
102. PO-03-037 TWO-YEAR OUTCOMES OF MICRA AV LEADLESS PACEMAKERS IN THE MICRA AV CED STUDY
103. PO-02-172 OUTCOMES OF PRIMARY AND SECONDARY PREVENTION SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR: A SINGLE-CENTER EXPERIENCE
104. MP-470553-008 RISING BURDEN OF STROKE AND ATRIAL FIBRILLATION RELATED MORTALITY IN THE UNITED STATES FROM 1999-2020
105. MP-470545-009 TRENDS AND PREDICTORS OF INAPPROPRIATE SHOCKS IN PATIENTS WITH SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
106. MP-470545-007 GENDER BASED OUTCOMES OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
107. MP-470545-005 PREDICTORS OF MONOMORPHIC VENTRICULAR TACHYCARDIA IN PATIENTS WITH SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
108. CE-482889-005 THE IMPACT OF SEX ON OUTCOMES ASSOCIATED WITH THE SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
109. MP-470547-003 LEADLESS PACEMAKER EXTRACTION: A SINGLE-CENTER EXPERIENCE
110. PO-06-096 CONTEMPORARY TRENDS IN CARDIAC ARREST AND HEART FAILURE RELATED MORTALITY IN THE UNITED STATES FROM 1999-2020
111. PO-06-025 ATRIOVENTRICULAR LEADLESS PACEMAKER IMPLANT IN PATIENTS WITH PRIOR DEVICE INFECTIONS: RESULTS FROM THE MICRA AV POST-APPROVAL REGISTRY
112. Management of Atrial Fibrillation in Elderly Adults
113. The Design of the Understanding Outcomes with the S‐ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED)
114. Correlation between AV synchrony and device collected AM‐VP sequence counter in atrioventricular synchronous leadless pacemakers: A real‐world assessment.
115. Prediction of New Onset Atrial Fibrillation After Cardiac Revascularization Surgery
116. Leadless Pacing—Uncertainties Remain About Safety and Efficacy—Reply
117. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
118. Device‐related infection associated with increased mortality risk in de novo transvenous implantable cardioverter‐defibrillator medicare patients
119. Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker
120. Abstract 12087: Device-Related Infection Associated With Increased Mortality Risk in de novo Transvenous Implantable Cardioverter-Defibrillator Medicare Patients
121. Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up
122. Cardiac Devices Recalls, Consequences and Management
123. Pulse Generator Exchange Does Not Accelerate the Rate of Electrical Failure in a Recalled Small Caliber ICD Lead
124. Predictors of Long-Term Survival Following Transvenous Extraction of Defibrillator Leads
125. Aspergillus endocarditis: a review of the literature
126. B-PO02-038 INITIAL REAL WORLD OPERATION OF A LEADLESS VENTRICULAR PACEMAKER PROVIDING ATRIOVENTRICULAR SYNCHRONOUS PACING
127. B-AB07-02 SPONTANEOUS FLUCTUATIONS IN ATRIAL FIBRILLATION BURDEN IN PATIENTS WITH IMPLANTABLE DEVICES: IMPLICATIONS FOR INCORPORATING BURDEN INTO STROKE RISK ASSESSMENT
128. B-PO03-183 SURVIVAL FOLLOWING THORACOSCOPIC SYMPATHECTOMY FOR REFRACTORY VENTRICULAR TACHYCARDIA
129. B-PO01-099 DO LONG-TERM CARDIAC RESYNCHRONIZATION THERAPY OUTCOMES DIFFER BASED ON IMPLANT INDICATION?
130. B-PO04-064 A PROSPECTIVE EVALUATION OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR INFECTIONS WITH MID TERM FOLLOW-UP
131. B-PO01-036 CARDIAC IMPLANTABLE TRANSVENOUS LEAD PERFORATION: INCIDENCE, OUTCOMES AND MANAGEMENT-IS LEAD REVISION NECESSARY?
132. B-PO05-038 IMPACT OF AGE ON PATIENT SELECTION IN LEADLESS PACEMAKER IMPLANT: EXPERIENCE WITH THE MICRA TRANSCATHETER PACEMAKER
133. B-PO04-144 SAFETY AND FEASIBILITY OF SAME DAY DISCHARGE AFTER PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION
134. B-PO02-069 THE IMPACT OF A NEW ALGORITHM TO REDUCE INAPPROPRIATE SHOCK RATES IN THE UNTOUCHED STUDY
135. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis
136. Process mapping strategies to prevent subcutaneous implantable cardioverter‐defibrillator infections.
137. Leadless pacemakers: A review of current data and future directions
138. Same day discharge after transvenous lead extraction: Balancing safety and efficiency.
139. The saga of tendril leads continues: Should we continue to bury our heads in the sand?
140. Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker
141. Transthoracic Dobutamine Stress Echocardiography in Patients Undergoing Bariatric Surgery
142. Impact of race and gender on cardiac device implantations
143. Esophageal Dissection Complicating Transesophageal Echocardiogram—The Lesson to Be Learned: Do Not Force the Issue
144. Life cycle management of Micra transcatheter pacing system: Data from a high‐volume center
145. Atrio‐ventricular synchronous pacing with a single chamber leadless pacemaker: Programming and trouble shooting for common clinical scenarios
146. Sex‐based differences in procedural complications associated with atrial fibrillation catheter ablation: A systematic review and meta‐analysis
147. Atrioventricular Nodal Reentrant Tachycardia Ablation in the Setting of Bilateral Femoral Vein Occlusion
148. Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up.
149. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry.
150. Diagnostic Pacing Maneuvers for Supraventricular Tachycardia Discrimination: a Taxonomic Approach.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.